← Open Payments lookup

SCOTT OSABUOHIEN: Open Payments

NPI 1376281477 · DRAPER, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$684 in 31 payments from 13 companies in 2025. Trend: 2023 $642 · 2024 $590 · 2025 $684

Food & beverage: $684
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$88
Vanda Pharmaceuticals Inc.3$88
ABBVIE INC.4$80
Janssen Pharmaceuticals, Inc4$77
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$62
Otsuka America Pharmaceutical, Inc.3$58
Teva Pharmaceuticals USA, Inc.3$58
Alkermes, Inc.2$44
Supernus Pharmaceuticals, Inc.2$42
Axsome Therapeutics, Inc.1$32

Products named: INGREZZA, FANAPT, VRAYLAR, SPRAVATO, REXULTI, CAPLYTA, AUSTEDO XR, ARISTADA.

Industry payments across UT — which companies pay providers there.